ClinicalTrials.gg
Not yet recruitingNCT07047040Updated Aug 1, 2025

Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin

A Phase 2/3 interventional study of Ketorolac Tromethamine 30 MG/ML Prefilled Syringe and Gabapentin in Pain, Postoperative and Osteoarthritis, Knee, sponsored by Assiut University. Not yet recruiting at 1 site in Egypt. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-08-01.

Sponsored by Assiut University · Phase 2/3, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2/3
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies testing Ketorolac Tromethamine in Pain, Postoperative — 3 open to participants now, 3 under way, 1 of them phase 3. Ketorolac Tromethamine · Pain, Postoperative.

Planned enrollment
10th of 23
86 · median 80
Started
2025
with 1 other
Phase 2/3
2 of 23
1 open now
Registered
23rd of 23
by date
Lead sponsor
1 of 23
Assiut University

Among the 23 studies testing Ketorolac Tromethamine in Pain, Postoperative, this one is the 10th largest by planned enrollment, is one of 2 that started in 2025, is one of 2 in phase 2/3, and was the 23rd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

3 of the 23 studies testing Ketorolac Tromethamine in Pain, Postoperative are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

About Ketorolac Tromethamine

Ketorolac Tromethamine: first FDA approval 1989 (TORADOL), first EMA approval 2015. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies testing Ketorolac Tromethamine in Pain, Postoperative, or all of them as a file.
02

Study summary

Evaluation of the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA

Read the detailed description

Elective total knee arthroplasty (TKA) is the gold standard for management of arthritis-associated pain and disability in osteoarthritis patients who have failed non-operative treatment modalitiesFollowing TKA, patients experience severe pain mediated by multiple pathways Painful stimuli to the body are detected by the free endings of peripheral nerves called nociceptors. Pre-emptive analgesia is analgesia given before the onset of painful stimuli to prevent central sensitization of nervous system to subsequent stimuli that could increase pain Studies have shown that pre-emptive analgesia reduce immediate postoperative pain and also prevent the development of chronic pain by decreasing altered sensory processing . Multimodal analgesia is the rational approach to pain management since no single analgesia targets all types of pain Multimodal analgesia, which is the use of at least 2 agents with differing mechanisms for pain control, has been shown to reduce hospital length of stay by 1.2 days and rehabilitation length of stay by 10 to 13 days compared with traditional postoperative analgesia. Ketorolac is a non-steroidal anti-inflammatory drug (NSAID). It is a cost-effective non selective cox inhibitor it inhibits prostaglandin biosynthesis. It is a potent analgesic with moderate anti-inflammatory.it inhibits platelet aggregation and increases bleeding time GABA analogues like Gabapentin is a structural analogue of gamma amino butyric acid, which was introduced in 1994 as an antiepileptic drug, particularly for partial seizures These drugs supress the hyper excitability of dorsal horn neurons caused due to tissue damage. They are also known to bind to the alpha 2 - delta subunit of voltage gated calcium channels and they have anxiolytic effect In this study we will assess the analgesic efficacy of pre-operative dose of combined ketorolac and Gabapentin in patients undergoing TKA.

03

Conditions studied

  • Pain, Postoperative
  • Osteoarthritis, Knee

Keywords

  • total knee replacement
  • pre-operative analgesia
  • ketorolac
  • gabapentin
04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients Undergoing Unilateral Total Knee Replacement from 40 years old to 80 years old

Exclusion criteria

Exclusion Criteria:

  • Rheumatoid Arthritis History of Renal impairment Patients refused to be enrolled in the study
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
86 participants (estimated)

Study arms

  • Active comparator
    Experimental group

    Experimental group will receive single dose of gabapentin 800 mg capsule and ketorolac 30 mg Ampule, one hour prior to administration of spinal anesthesia

    Drug: Ketorolac Tromethamine 30 MG/ML Prefilled Syringe · Drug: Gabapentin

  • Placebo comparator
    control group

    control group will receive normal saline ampule and empty capsule one hour prior to administration of spinal anesthesia

    Drug: Empty Medication Capsules

Interventions

  • DrugKetorolac Tromethamine 30 MG/ML Prefilled Syringe

    Drug page: Ketorolac TromethamineStudies of Ketorolac TromethamineKetorolac Tromethamine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

  • a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

  • DrugEmpty Medication Capsules

    two empty capsules of gabapentin

06

What researchers measure

Primary outcomes

  1. evaluate the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA.

    asses pain postoperatively at 6,12,24 hours using VAS score

    Time frame: during the first 24 hours post-operatively

Secondary outcomes

  1. assess the impact of pre-operative ketorolac and gabapentin on post-operative opioid consumption

    by recording the total amount of opioids in both groups and comparing them

    Time frame: during the first 24 hours post-operatively

  2. investigate the safety profile of pre-operative ketorolac and gabapentin

    by recording any side effects of these drugs during the study

    Time frame: during the first 24 hours post-operatively

  3. evaluate the effect of pre-operative ketorolac and gabapentin on functional recovery

    by using Time UP and Go(TUG) Test in both groups and comparing them

    Time frame: during the month after surgery

07

Study locations

1 site
08

References and documents

Publications

  • Skinner HB. Multimodal acute pain management. Am J Orthop (Belle Mead NJ). 2004 May;33(5 Suppl):5-9. PubMed 15195936 ↗
  • Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. doi: 10.1097/00000542-199907000-00006. PubMed 10422923 ↗
  • Hebl JR, Dilger JA, Byer DE, Kopp SL, Stevens SR, Pagnano MW, Hanssen AD, Horlocker TT. A pre-emptive multimodal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Reg Anesth Pain Med. 2008 Nov-Dec;33(6):510-7. PubMed 19258965 ↗
  • Lee BH, Park JO, Suk KS, Kim TH, Lee HM, Park MS, Lee SH, Park S, Lee JY, Ko SK, Moon SH. Pre-emptive and multi-modal perioperative pain management may improve quality of life in patients undergoing spinal surgery. Pain Physician. 2013 May-Jun;16(3):E217-26. PubMed 23703420 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2025; primary completion for Oct 2027, 26 months later.

Of 49 non-industry phase 2/3 interventional studies under Pain, Postoperative, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's planned 26 months is above that.

Counting every sponsor, half of 52 studies reached it within 17 months; a quarter within 10 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2025
First posted
Jul 2, 2025
StartEst.
Aug 15, 2025
Primary completionEst.
Oct 30, 2027
CompletionEst.
Dec 30, 2027
Last update
Aug 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07047040
Lead sponsor
Assiut University
Responsible party
Nour Shaaban Abdel-Aleem Mohamed (Resident, Assiut University) — Principal investigator
First posted
Jul 2, 2025
Start date
Aug 15, 2025 (estimated)
Primary completion
Oct 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Aug 1, 2025

Study contacts

Nour Shaaban Abdel-Aleem, Resident
Contact
Nour.162663325@med.aun.eg
+00201157257047
Mohamed Ahmed Mahran, Professor
Contact
drmahran@aun.edu.eg
+00201006134669
Hatem Mohamed Bakr, Professor
study director · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ketorolac Tromethamine · Gabapentin

Start the discussion